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Abstract
Animal models of gentamicin nephrotoxicity present acute tubular necrosis associated with inflammation, which can contribute 
to intensify the renal damage. Hydrogen sulfide (H2S) is a signaling molecule involved in inflammation. We evaluated the effect 
of DL-propargylglycine (PAG), an inhibitor of endogenous H2S formation, on the renal damage induced by gentamicin. Male 
Wistar rats (N = 8) were injected with 40 mg/kg gentamicin (im) twice a day for 9 days, some of them also received PAG (N = 
8, 10 mg·kg-1·day-1, ip). Control rats (N = 6) were treated with saline or PAG only (N = 4). Twenty-four-hour urine samples were 
collected one day after the end of these treatments, blood samples were collected, the animals were sacrificed, and the kidneys 
were removed for quantification of H2S formation and histological and immunohistochemical studies. Gentamicin-treated rats 
presented higher sodium and potassium fractional excretion, increased plasma creatinine [4.06 (3.00; 5.87) mg%] and urea 
levels, a greater number of macrophages/monocytes, and a higher score for tubular interstitial lesions [3.50 (3.00; 4.00)] in the 
renal cortex. These changes were associated with increased H2S formation in the kidneys from gentamicin-treated rats (230.60 
± 38.62 µg·mg protein-1·h-1) compared to control (21.12 ± 1.63) and PAG (11.44 ± 3.08). Treatment with PAG reduced this 
increase (171.60 ± 18.34), the disturbances in plasma creatinine levels [2.20 (1.92; 4.60) mg%], macrophage infiltration, and 
score for tubular interstitial lesions [2.00 (2.00; 3.00)]. However, PAG did not interfere with the increase in fractional sodium 
excretion provoked by gentamicin. The protective effect of PAG on gentamicin nephrotoxicity was related, at least in part, to 
decreased H2S formation.
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The principal side effect of gentamicin is acute tubular 
necrosis with acute renal failure observed in about 20% 
of exposed patients and can reach 58% of the patients in 
intensive care units (1). Recovery of baseline renal func-
tion is slow and may be incomplete, probably because of 
permanent loss of nephrons. Animal models of gentamicin 
nephrotoxicity show acute tubular necrosis associated with 
inflammation in the renal cortex (2,3). The inflammatory 
process can contribute to intensifying the renal damage. 
Lymphocytes and macrophages present in the inflammatory 
process can mediate the injury through various mechanisms, 
including generation of reactive oxygen species, nitric oxide, 
complement factors, and pro-inflammatory cytokines (4).
Hydrogen sulfide (H2S) is an important signaling mol-
ecule involved in inflammation (5-7). This gas is synthesized 
in the body from L-cysteine by different pathways in which 
several enzymes are involved, such as: cystathionine-γ-
lyase (CSE), cystathionine β-synthase (CBS), 3-mercap-
topyruvate sulfurtransferase, cysteine aminotransferase, 
and cysteine lyase (6). Pretreatment of animals with 
DL-propargylglycine (PAG), a CSE inhibitor, reduced the 
formation of tissue H2S and inflammation induced by 
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lipopolysaccharide, decreased the activity of hepatic my-
eloperoxidase (a marker for neutrophil infiltration) and the 
tissue damage (5). In a recent study from our laboratory, 
we observed that treatment with PAG reduced the renal 
damage induced by cisplatin injection (8). This effect was 
related to the reduction of H2S formation and the reduction 
of the inflammation in the kidneys of PAG+cisplatin-treated 
rats. H2S also has anti-inflammatory activity depending on 
its rate of generation (6). It was observed that H2S at physi-
ological concentrations presents anti-inflammatory effects 
(9). The present study evaluated the effect of PAG on the 
renal damage induced by gentamicin, when administered 
4 h after the initiation of gentamicin treatment. PAG is an 
irreversible inhibitor of CSE and, when administered to 
rodents, produces an almost complete inhibition of the 
activity of this enzyme (10), is well absorbed and rapidly 
crosses biological membranes (11). 
Material and Methods
Animals and experimental protocols
A total of 26 male Wistar rats (200-250 g) were provided 
by the Animal House of the Ribeirão Preto Campus, Univer-
sity of São Paulo (Ribeirão Preto, SP, Brazil) and housed in 
polycarbonate cages (4 animals per cage) under standard 
room temperature (25°C), and on a 12-h light/dark cycle 
with free access to standard rat chow and water. Eight 
rats were injected with gentamicin (Schering-Plough S/A, 
Brazil, 40 mg/kg, im, twice a day, for 9 days, 8 received 
gentamicin+PAG for 9 days, 4 with PAG alone (Sigma, USA), 
and 6 control rats were treated with 0.15 M NaCl solution. 
PAG was injected for 9 days (10 mg·kg-1·day-1, ip) starting 
on day one of gentamicin treatment and the injections were 
performed 4 h after the first daily injection of gentamicin 
and 4 h before the second. The dose and time selected for 
gentamicin or PAG treatment were based on recent studies 
performed in our laboratory (3,8). One day after the end 
of these treatments, 24-h urine samples were collected in 
metabolic cages; blood samples were also collected and 
the animals were sacrificed by excess anesthesia and 
the kidneys removed for H2S formation evaluation and 
histological and immunohistochemical studies. All experi-
mental procedures were conducted in accordance with the 
principles and procedures outlined in the National Institutes 
of Health (NIH) Guide for the Care and Use of Laboratory 
Animals, and the Animal Experimentation Committee of 
Faculdade de Medicina de Ribeirão Preto, Universidade 
de Paulo, approved the study protocol.
Renal function studies
One day after the end of these treatments the rats of 
all groups were placed in metabolic cages and 24-h urine 
samples were collected to measure creatinine, sodium and 
potassium. Plasma samples were then collected and the 
kidneys removed. Plasma creatinine and blood urea nitrogen 
were measured using commercial kits (Labtest Diagnostica 
S.A., Brazil), and sodium and potassium were determined 
in plasma and urine using flame photometry (model 262; 
Micronal, Brazil). Urine creatinine was measured in order 
to calculate fractional sodium and potassium excretion by 
dividing sodium or potassium clearance (UNa or UK x V / PNa 
or PK) by creatinine clearance (Ucreat x V) / Pcreat, where 
UNa and UK = urinary sodium and potassium concentrations; 
V = urinary volume/min; PNa or PK = plasma sodium and 
potassium concentrations and Ucreat and Pcreat = urinary 
and plasma creatinine concentrations.
Light microscopy studies
The kidneys were sectioned transversely, fixed in 4% 
paraformaldehyde, postfixed in Bouin’s solution for 4-6 h, 
and processed for paraffin embedding. Histological sec-
tions (4-μm thick) were stained with Masson’s trichrome 
and examined under the light microscope. Tubulointerstitial 
damage was defined as tubular necrosis, inflammatory cell 
infiltrate, tubular lumen dilation, or tubular atrophy. Damage 
was scored on a scale of 0 to 4 [0 = normal; 0.5 = small focal 
areas; 1 = involvement of less than 10% of the cortex; 2 = 
10-25% involvement of the cortex; 3 = 25-75% involvement 
of the cortex; 4 = extensive damage involving more than 
75% of the cortex (12)]. 
Antibodies
The macrophage/monocyte infiltrations in renal tissue 
related to the inflammatory process were evaluated using 
a monoclonal antibody (ED1; Serotec, UK) that only reacts 
against antigens present in the cytoplasm of macrophages 
and monocytes. Tubular cell lesions were evaluated using 
a monoclonal antibody against vimentin (Dako, Denmark). 
Tubular cells only express vimentin when they are prolifer-
ating. Therefore, increased vimentin expression in tubular 
cells suggests recent tubular cell injury (13). 
Immunohistochemical study
Kidney sections were submitted to immunohistochemi-
cal study (13). The sections were incubated for 1 h with 
1/1000 monoclonal anti-ED1 or with 1/500 monoclonal 
anti-vimentin antibodies. The reaction product was de-
tected with an avidin-biotin-peroxidase complex (Vector 
Laboratories, USA). The color reaction was developed 
with 3,3’-diaminobenzidine (DAB; Sigma). The sections 
were counterstained with methyl green, dehydrated and 
mounted. Negative controls were created by replacing the 
primary antibody with equivalent concentrations of normal 
mouse immunoglobulin G. For the evaluation of the im-
munoperoxidase stain for vimentin each grid field of renal 
cortex measuring 0.245 mm2 was graded semiquantitatively, 
and the mean score per biopsy was calculated. Each score 
reflected mainly the changes in the extent rather than the 
intensity of staining and depended on the percentage of 
the grid field showing positive staining: 0 = absent staining 
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or less than 5% of stained area; I = 5 to 25%; II = >25 to 
50%, III = >50 to 75%, and IV = >75%. Immunoperoxidase 
staining for ED1 was determined by counting the positive 
cells (infiltrating macrophages and monocytes) in the renal 
cortical tubulointerstitium by the examination of 30 grid 
fields, measuring 0.100 mm2 each, and the mean counts 
per area of 0.245 mm2 per kidney were calculated (13). 
The evaluation of renal histology and immunohistochemi-
cal studies were performed in a blind way by two different 
observers.
Assay of H2S synthesis
H2S biosynthesis was measured as described previ-
ously (14). Whole kidney cortical tissue from the rats were 
homogenized in 100 mM potassium phosphate buffer, pH 
7.4, using a Polytron device. Each sample (200 µL, 50% 
weight/volume) containing 20 µL 10 mM L-cysteine, 20 µL 2 
mM pyridoxal 5’-phosphate, and 30 µL PBS was incubated 
for 2 h at 37°C. Zinc acetate (1% (w/v); 100 µL) was then 
added to trap evolved H2S, followed by trichloroacetic acid 
(10% (w/v); 100 µL) to precipitate protein and thus stop the 
reaction. After centrifugation, 50 µL 20 mM N,N-dimethyl-p-
phenylenediamine sulfate followed by 50 µL 30 mM FeCl3 
were then added to 50 µL supernatant, and absorbance 
at 670 nm was measured. The H2S concentration of each 
sample was calculated against a calibration curve of 100-
0.1 µg/mL NaHS. All reagents used in this assay were 
from Sigma.
Statistical analysis
Data concerning plasma urea and creatinine levels, 
sodium and potassium fractional excretion, and scores 
for tubulointerstitial lesions were analyzed statistically us-
ing the nonparametric Kruskal-Wallis test followed by the 
Dunn post-test. These data are reported as median and 
interquartile range (25-75% percentile). For data related to 
the other parameters studied we used analysis of variance 
with the multiple comparisons Newman-Keuls test. These 
data are reported as means ± SEM. The level of statistical 
significance was set at P < 0.05.
Results
Gentamicin-treated rats presented increases in plasma 
creatinine and urea levels and in sodium and potassium 
fractional excretions compared to control. Treatment with 
PAG attenuated the increase in plasma creatinine and urea 
levels and in fractional potassium excretion provoked by 
gentamicin. However, PAG did not prevent the increase of 
fractional sodium excretion observed in gentamicin-treated 
rats. PAG only-treated rats did not present differences 
in any parameter of renal function studied compared to 
controls (Table 1).
Light microscopy study of the renal cortex of both groups 
of gentamicin-treated rats, sacrificed 2 days after the end of 
these treatments, showed the following morphological fea-
tures: tubular cell necrosis, tubular lumen dilation, denuda-
tion of the tubular basement membrane, intraluminal casts, 
swelling/flattening of proximal tubular cells with brush border 
loss, diffuse interstitial edema, and interstitial inflammatory 
cell infiltrates. Glomerular morphology was unchanged. 
However, the score for tubulointerstitial lesions of renal 
cortex was higher in rats of the gentamicin group than in 
rats of the gentamicin+PAG group (P < 0.01; Figure 1A and 
B; Table 2). The immunohistochemical analysis for vimentin 
showed that gentamicin-treated rats presented high vimentin 
expression in the tubular cells of the renal cortex compared 
to controls, suggesting recent cell injury. This alteration was 
less intense in the animals of the gentamcin+PAG group 
(P < 0.01; Figure 1C and D; Table 2).
The data of the immunohistochemical study also showed 
that gentamicin-treated rats presented greater macrophage/
monocyte numbers than the control group (Figure 1E and 
F), and this was associated with tubulointerstitial injury. 
Treatment with PAG, an inhibitor of H2S formation, reduced 
macrophage infiltration (P < 0.01; Table 2).
Table 1. Parameters of renal function of saline-, PAG-, gentamicin-, and gentamicin+PAG-treated rats 2 days after the 
end of the treatment.
Saline (N = 6) PAG (N = 4) Gentamicin (N = 8) Gentamicin+PAG (N = 8)
Pcreat (mg/mL) 0.49 (0.21; 0.61) 0.48 (0.46; 0.51) 4.06* (3.00; 5.87) 2.20 (1.92; 4.60)
BUN (mg/mL) 43.38 (34.10; 48.80) 46.30 (41.70; 56.10) 510.10* (400.80; 637.40) 263.80#* (206.60; 476.20)
FENa+ (%) 0.42 (0.32; 0.66) 0.66 (0.49; 0.70) 9.63* (7.34; 16.61) 8.60* (6.71; 20.87)
FEK+ (%) 44.37 (38.81; 52.80) 41.87 (36.96; 43.41) 181.10* (252.50; 234.40) 150.20 (136.70; 217.30)
Saline (0.15 M NaCl, im) and gentamicin (40 mg/kg, im) were injected twice a day for 9 days. PAG 
(10 mg·kg-1·day-1, ip) was injected for 9 days starting on day one of gentamicin treatment and the injections were per-
formed 4 h after the first daily injection of gentamicin and 4 h before the second. PAG = DL-propargylglycine; Pcreat = 
plasma creatinine; BUN = blood urea nitrogen; FE = fractional excretion. Data are reported as median and interquartile 
ranges (25-75% percentile). *P < 0.01 compared to saline; #P < 0.05 compared to gentamicin (Kruskal-Wallis test fol-
lowed by the Dunn post-test). 
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Figure 1. Masson’s trichrome-stained histological sections (A and B) and immunolocalization of vimentin (C and D) and ED1+ cells 
(macrophages/monocytes; E and F) from the renal cortex of rats treated with gentamicin (A, C, E) or gentamicin+PAG (B, D, F), 2 
days after the end of the treatment. Note the presence of tubular necrosis (black arrow) and the increase of relative interstitial area in 
A (asterisk). This alteration was less intense in B. Vimentin expression (white arrows) and the number of ED1+ cells (dotted arrows) 
were higher in C and E than in D and F. Magnification bars = 20 µm.
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A significant increase in H2S formation (µg·mg protein-1·h-1) 
was observed in the kidneys from gentamicin-treated rats 
(230.60 ± 38.62) compared to control (21.12 ± 1.63) and 
PAG (11.44 ± 3.08) (P < 0.01). Treatment with PAG attenu-
ated the increase of H2S provoked by gentamicin injection 
(171.60 ± 18.34; P < 0.05) by 25%. 
Discussion
Experimental and clinical studies have shown that 
gentamicin treatment can provoke acute tubular necrosis 
with acute renal failure (1). Animal models of gentamicin 
nephrotoxicity show acute tubular necrosis associated 
with inflammation that contributes to intensifying the renal 
damage (2,3). In previous studies, we observed increased 
renal expression of cytokines such as transforming growth 
factor-beta (TGF-β), endothelin and angiotensin II in the 
renal cortex of rats sacrificed five days after the cessa-
tion of gentamicin treatment, which was related to renal 
functional and structural disturbances presented by these 
animals (2). These rats also presented activation of nuclear 
factor κB (NF-κB) and macrophage infiltration in the renal 
cortex (3).
The results of the present study showed that rats in-
jected with gentamicin for 9 days and sacrificed two days 
after the end of this treatment presented higher plasma 
creatinine and urea levels, increased fractional sodium 
and potassium excretions, as well as higher numbers of 
macrophages/monocytes, tubular interstitial lesions and 
increased vimentin expression in tubular cells of the renal 
cortex compared to control. These changes were associated 
with an 11-fold increase of H2S. The macrophage infiltration 
in the interstitial area from the renal cortex of gentamicin-
treated rats was intense and diffuse. Macrophages can be 
involved in the inflammatory process that can progress to 
fibrosis in gentamicin nephrotoxicity (2,3). They are able to 
release peptides such as TGF-β, interleukin-1, endothelin, 
and angiotensin II (15). Treatment with PAG, an inhibitor of 
H2S formation, reduced the macrophage infiltration and the 
tubulointerstitial lesions, as well as the increases in plasma 
urea and creatinine levels provoked by gentamicin injec-
tion. PAG did not interfere with the higher fractional sodium 
excretion in gentamicin-treated rats. Although the tubular 
cell lesions were less intense in the animals treated with 
gentamicin plus PAG than in those injected with gentamicin 
alone, the renal protection conferred by PAG was related 
to the decrease in the inflammatory process, which also 
interfered with renal hemodynamics and glomerular filtra-
tion rate. Several mediators released by the inflammatory 
cells such as angiotensin II and endothelin can provoke an 
increase in renal arteriole resistance, leading to a decrease 
in renal blood flow (2). Therefore, this protective effect of 
PAG on renal hemodynamics may be more effective than 
on the tubular cell lesions. In addition, although PAG pro-
voked a 25% decrease in the higher levels of H2S formation 
induced by gentamicin treatment in rats, the H2S levels 
were still higher in the renal cortex of the animals treated 
with gentamicin+PAG compared to control. 
The increased biosynthesis of H2S has been demon-
strated in several animal models of inflammatory disease 
(septic/endotoxic and hemorrhagic shock, pancreatitis 
and carrageenan-induced hind paw edema in rats) and 
the inhibition of H2S formation reduces the inflammation 
in these cases (5,16). However, the exact role of this gas 
on the inflammatory process is not known. In a study from 
our laboratory, we found that the role of H2S in the inflam-
matory process cannot be direct, since the incubation of 
tubular epithelial cells with NaHS (a donor of H+ and S2- for 
the synthesis of H2S) did not modify cell viability (8). H2S 
can induce neutrophil adhesion and locomotion during the 
inflammatory response by a mechanism dependent on 
ATP-sensitive potassium channels (7). Neutrophils release 
cytotoxic and pro-inflammatory mediators such as arachi-
donic acid metabolites, cytokines/chemokines, oxygen- and 
nitrogen-derived free radicals that have potent chemotactic 
effects leading to macrophage infiltration and kidney injury 
(17). H2S can inhibit or activate NF-κB depending on the 
stage of inflammation. NF-κB activation in the early stages 
Table 2. Score for tubulointerstitial lesions (TIL), vimentin and number of ED1+ cells (macrophages/
monocytes) in the renal cortex of saline-, PAG-, gentamicin-, and gentamicin+PAG-treated rats two 
days after the end of treatment.
Saline (N = 6) PAG (N = 4) Gentamicin (N = 8) Gentamicin+PAG (N = 8)
TIL 0 0 3.50* (3.00; 4.00) 2.00#* (2.00; 3.00)
Vimentin 0.10 (0.06; 0.12) 0.13 (0.004; 0.200) 2.89* (2.84; 3.43) 1.84#* (1.69; 2.42)
ED1+ cells 4.94 ± 0.61 6.66 ± 0.41 154.30* ± 7.67 90.29#* ± 8.68
Data are reported as median and interquartile range (25-75% percentile) for TIL and vimen-
tin (data compared by the Kruskal-Wallis test followed by the Dunn post-test) or mean ± SEM for 
ED1+ cells (data compared using analysis of variance with the multiple comparisons Newman-
Keuls test). Drug treatments are given in the legend to Table 1. PAG = DL-propargylglycine. 
*P < 0.01 compared to saline; #P < 0.01 compared to gentamicin. 
Gentamicin-induced renal damage 249
www.bjournal.com.br Braz J Med Biol Res 45(3) 2012
of inflammation can lead to increased expression of several 
inflammatory substances such as cytokines, chemokines 
and adhesion molecules, intensifying the inflammatory 
process (7). Zhang et al. (18) observed that H2S may 
induce an increase in tissue levels of adhesion molecules 
and promote leukocyte-endothelium interaction in sepsis 
through a mechanism involving the activation of NF-κB. 
In another study, Zhang et al. (19) observed that in-
traperitoneal administration of PAG led to a peak serum 
concentration within 1 to 2 h, followed by rapid excretion in 
urine. Kodama et al. (20) showed that intraperitoneal PAG 
injection in rats resulted in almost complete inhibition of liver 
CSE activity (without any effect on CBS) within 120 min.
Our data show that treatment with PAG, an inhibitor of 
H2S formation, reduces disturbances in renal function as 
well as macrophages infiltration in renal cortex and tubule 
interstitial lesions provoked by gentamicin. The protective 
effect of PAG on gentamicin nephrotoxicity was associated 
with a reduction of H2S formation.
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